CN1333339A - M×a蛋白质的多型基因及其应用 - Google Patents
M×a蛋白质的多型基因及其应用 Download PDFInfo
- Publication number
- CN1333339A CN1333339A CN01122058A CN01122058A CN1333339A CN 1333339 A CN1333339 A CN 1333339A CN 01122058 A CN01122058 A CN 01122058A CN 01122058 A CN01122058 A CN 01122058A CN 1333339 A CN1333339 A CN 1333339A
- Authority
- CN
- China
- Prior art keywords
- polynucleotide
- sequence
- interferon
- mentioned
- individuality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
Abstract
Description
Claims (17)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000080955 | 2000-03-22 | ||
JP080955/2000 | 2000-03-22 | ||
JP2001062371A JP3983985B2 (ja) | 2000-03-22 | 2001-03-06 | MxAタンパク質の多型遺伝子およびその使用 |
JP062371/2001 | 2001-03-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1333339A true CN1333339A (zh) | 2002-01-30 |
CN1169824C CN1169824C (zh) | 2004-10-06 |
Family
ID=26588106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011220589A Expired - Fee Related CN1169824C (zh) | 2000-03-22 | 2001-03-22 | M×a蛋白质的多型基因及其应用 |
Country Status (7)
Country | Link |
---|---|
US (1) | US6783935B2 (zh) |
EP (1) | EP1136571A3 (zh) |
JP (1) | JP3983985B2 (zh) |
KR (1) | KR100452027B1 (zh) |
CN (1) | CN1169824C (zh) |
TW (1) | TWI250212B (zh) |
WO (1) | WO2001071007A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4021627B2 (ja) | 2000-03-22 | 2007-12-12 | 株式会社東芝 | 遺伝子検出用担体、及びインターフェロン療法の有効性を検出するためのその使用 |
US20040043379A1 (en) * | 2001-03-27 | 2004-03-04 | Koji Hashimoto | Method of detectingnucleic acid relating to disease |
JP2004041109A (ja) * | 2002-07-12 | 2004-02-12 | Toshiba Corp | 核酸検出方法およびそれに使用されるプライマー |
US7405043B2 (en) | 2004-06-29 | 2008-07-29 | Vita Genomics, Inc. | Responsiveness to therapy for liver disorders |
US20080125333A1 (en) * | 2006-05-31 | 2008-05-29 | Antara Biosciences Inc. | Devices and kits for detecting one or more target agents |
US20080026394A1 (en) * | 2006-07-11 | 2008-01-31 | Antara Biosciences Inc. | Methods of detecting one or more cancer markers |
US20100028868A1 (en) * | 2008-07-29 | 2010-02-04 | Yuchi Hwang | Responsiveness to Therapy for Liver Disorders |
US8535887B2 (en) * | 2009-05-21 | 2013-09-17 | Merck Sharp & Dohme Corp. | Genetic markers associated with interferon-alpha response |
FR2969299B1 (fr) | 2010-12-15 | 2016-03-04 | Ct Hospitalier Universitaire Montpellier | Procede pour predire la reponse a un traitement contre l'hepatite c |
US20130344565A1 (en) * | 2012-06-21 | 2013-12-26 | Rapid Pathogen Screening, Inc. | Optimization of Expression and Purification of Recombinant Human MxA Protein in E. Coli |
TWI726291B (zh) | 2013-01-07 | 2021-05-01 | 英屬維爾京群島商遠東超級實驗室有限公司 | 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物 |
CN113604555B (zh) * | 2021-08-02 | 2023-05-23 | 中山大学 | 与h7n9禽流感易感性相关的标记物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5350190A (en) * | 1989-05-19 | 1990-12-18 | University Of Texas System, The | Methods and compositions for the identification of patients sensitive to interferon alpha |
US5776672A (en) | 1990-09-28 | 1998-07-07 | Kabushiki Kaisha Toshiba | Gene detection method |
WO1994002606A1 (en) * | 1992-07-20 | 1994-02-03 | The Government Of The United States Of America, Asrepresented By The Secretary Of The Department Of Health And Human Services | Inhibition of retroviral expression by interferon-induced cellular genes and proteins |
JPH09511908A (ja) * | 1994-04-14 | 1997-12-02 | リガンド・ファーマシューティカルズ・インコーポレイテッド | サイトカインに応答性のdna調節要素 |
-
2001
- 2001-03-06 JP JP2001062371A patent/JP3983985B2/ja not_active Expired - Fee Related
- 2001-03-16 KR KR10-2001-0013607A patent/KR100452027B1/ko not_active IP Right Cessation
- 2001-03-21 TW TW090106628A patent/TWI250212B/zh not_active IP Right Cessation
- 2001-03-22 WO PCT/JP2001/002296 patent/WO2001071007A2/en unknown
- 2001-03-22 CN CNB011220589A patent/CN1169824C/zh not_active Expired - Fee Related
- 2001-03-22 US US09/813,990 patent/US6783935B2/en not_active Expired - Fee Related
- 2001-03-22 EP EP01302708A patent/EP1136571A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1136571A2 (en) | 2001-09-26 |
KR20010092687A (ko) | 2001-10-26 |
US20020127558A1 (en) | 2002-09-12 |
CN1169824C (zh) | 2004-10-06 |
WO2001071007A2 (en) | 2001-09-27 |
WO2001071007A3 (en) | 2003-06-12 |
JP2001333785A (ja) | 2001-12-04 |
EP1136571A3 (en) | 2002-11-13 |
US6783935B2 (en) | 2004-08-31 |
KR100452027B1 (ko) | 2004-10-08 |
JP3983985B2 (ja) | 2007-09-26 |
TWI250212B (en) | 2006-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1250744C (zh) | 确定二氢嘧啶脱氢酶基因表达的方法 | |
AU2016202211B2 (en) | Improved Method and Kit for Determining Severity and Progression of Periodontal Disease | |
CN101054601A (zh) | 一种检测细胞色素p450酶系突变位点的寡核苷酸探针及基因芯片 | |
CN101031658A (zh) | 病毒和病毒相关mirna及其用途 | |
CN1333339A (zh) | M×a蛋白质的多型基因及其应用 | |
CN101034061A (zh) | 生物芯片检测单核苷酸多态性的方法 | |
CN101619351B (zh) | 一种糖尿病药物治疗相关基因突变的检测方法及其专用芯片和试剂盒 | |
US20070092909A1 (en) | Molecular markers for identification of fat and lean phenotypes in chickens | |
CN1333377A (zh) | 基因检测用载体,及检测干扰素疗法有效性的应用 | |
CN111118138A (zh) | 一种叶酸代谢能力基因mthfr和mtrr多态性检测试剂盒及方法 | |
CN1810989A (zh) | 一种等温反应检测具序列特异性的dna和rna的方法 | |
KR101359782B1 (ko) | 간세포암종의 재발 진단용 단일 염기 다형성 | |
CN101619350A (zh) | 用于恶性肿瘤个体化用药相关基因突变检测的基因芯片及其应用 | |
WO2019160136A1 (ja) | ブリ類の性識別方法 | |
CN101041854A (zh) | 一种原发性肝癌相关非编码小分子rna的多态性位点及其应用 | |
CN1840697A (zh) | 确定二氢嘧啶脱氢酶基因表达的方法 | |
CN101031657A (zh) | 微小rna及其用途 | |
CN115976226A (zh) | Snp标记在近交系小鼠品系鉴定中的应用及引物序列 | |
CN1563421A (zh) | 乙醇代谢相关酶基因多态性检测芯片及其制备方法和用途 | |
EP1436756B1 (en) | Polymorphic marker that can be used to assess the efficacy of interferon therapy | |
CN1678753A (zh) | 监测引物延伸和多态性检测反应的方法和组合物 | |
CN1331756A (zh) | 细胞色素表达的基因分型 | |
US20040209254A1 (en) | Diagnostic polymorphisms for the tgf-beta1 promoter | |
KR20200070935A (ko) | 참외의 품종 구별 및 f1 종자 순도검정을 위한 snp 기반 kasp용 프라이머 세트 및 이의 용도 | |
CN1726287A (zh) | 乙型肝炎病毒的耐药性的识别方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Patentee Correct: Toshiba Corp False: Toshiba K.K. Number: 40 Page: 461 Volume: 20 |
|
CI03 | Correction of invention patent |
Correction item: Patentee Correct: Toshiba Corp False: Toshiba K.K. Number: 40 Page: The title page Volume: 20 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: PATENTEE; FROM: CO., LTD. TOSHIBA TO: TOSHIBA CORPORATION |
|
ERR | Gazette correction |
Free format text: CORRECT: PATENTEE; FROM: CO., LTD. TOSHIBA TO: TOSHIBA CORPORATION |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041006 Termination date: 20100322 |